Fortnightly Review: Management of atopic eczema
- 1 April 1995
- Vol. 310 (6983) , 843-847
- https://doi.org/10.1136/bmj.310.6983.843
Abstract
Summary points Time for explanation and education is essential Adequate amounts of emollients should be prescribed, and these should be used liberally and frequently When prescribing topical corticosteroids the age of the patient, the site to be treated, and the extent of the disease are important considerations Deterioration in previously stable eczema may be due to secondary bacterial or viral infection or to development of a contact dermatitis Attempts to eradicate the house dust mite are not currently recommended Dietary restriction is of little or no benefit in adults, and in children it is worth trying only in selected infants under professional supervision Evidence for the therapeutic value of evening primrose oil remains inconclusive PUVA or UVB may be helpful in selected patientsKeywords
This publication has 41 references indexed in Scilit:
- The control of allergens of dust mites and domestic pets: a position paperClinical and Experimental Allergy, 1992
- Azathioprine in dermatologyJournal of the American Academy of Dermatology, 1991
- Cyclosporin A in atopic dermatitis: therapeutic resonse is disociated form effects on allergic reactonsBritish Journal of Dermatology, 1991
- Effects of maternal diet during late pregnancy and lactation on the development of atopic diseases in infants up to 18 months of age—in‐vivo resultsClinical and Experimental Allergy, 1989
- Steroid scare.Archives of Disease in Childhood, 1987
- Atopic eczema unresponsive to evening primrose oil (linoleic and γ-linolenic acids)Journal of the American Academy of Dermatology, 1985
- Prevalence, morbidity, and cost of dermatologie diseasesJournal of the American Academy of Dermatology, 1984
- Cutaneous Squamous-Cell Carcinoma in Patients Treated with PUVANew England Journal of Medicine, 1984
- Does infant feeding affect the risk of allergy?Archives of Disease in Childhood, 1983
- A NEW MARKER FOR HUMAN CANCER CELLS. 1. THE Ca ANTIGEN AND THE Cal ANTIBODYThe Lancet, 1982